Trevarx Biomedical, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States
Trevarx Biomedical, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $350,000 sold in a notice filed in 2025.
Trevarx Biomedical at a glance
What does Trevarx Biomedical do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2021 to 2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $350,000 sold (2025).
Frequently asked questions about Trevarx Biomedical
Where is Trevarx Biomedical headquartered?
Trevarx Biomedical, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Trevarx Biomedical do?
Trevarx Biomedical, Inc. is a biotechnology company.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences